>> Who is liable for their denial of treatment?
Doctors base their treatments on the best information they have at hand. In many cases, that information turns out to be faulty.
This retraction does not mean the HCQ works against COVID-19, only that this particular study is no proof that it does not work.
There are five scientific studies demonstrating this for outpatient use.
https://academic.oup.com/aje/advance-article/doi/10.1093/aje...
One of these "studies" is a 2-page Google Doc with no real data. Another is the discredited Raoult study, which is under investigation by the journal [1]. Another study cited is also by Raoult's team. The Brazil study (ref. 29) doesn't seem to have passed peer review (yet?) and has severe methodological flaws. Like the Raoult studies, the Brazil study was not randomized, but makes no attempt to control for confounding by indication or self-selection, such as with propensity score matching or similar methods commonly used in observational studies. The last study cited isn't a study, but an article from a local news station.
The death toll (CFR) in India is suspiciously lower than in the European states. Could it be because they're using Hydroxychroloquine more freely [0]? Though, that hasn't been without controversy [1].
[0] https://medicalxpress.com/news/2020-05-india-hydroxychloroqu...
[1] https://science.thewire.in/health/covid-19-indian-council-of...
>According to the ICMR study published in the Indian Journal of Medical Research (IJMR), consumption of four or more maintenance doses was associated with a significant decline (>80%) in the risk of Covid-19 infection among the ‘participants’. The study also found that there was no significant association between HCQ and adverse drug reactions.
https://health.economictimes.indiatimes.com/news/pharma/why-...
Link to the preliminary paper http://www.ijmr.org.in/preprintarticle.asp?id=285520
There are too many other, far more plausible, reasons why the death toll in India looks lower:
* Population pyramid - far fewer people aged 70+ as a percentage of the population means a far lower CFR
* Hotter weather which slows the spread of coronaviruses massively
* More sunlight means less vitamin-D deficiency (which seems to worsen infections)
* Low amount of travel to/from initial seeding spots means closing borders was effective (Wuhan, northern Italy, Alps)
And that is without casting any aspersions about causes of death being attributed correctly.
Hydroxychloroquine has been used since 1958 by millions of people. It is relatively safely (as much as any drug is safe) used for Malaria, Lupus and Arthritis. Some Lupus users have used it for decades.
The CDC on their web site state it is safe for young, old and pregnant.
https://www.cdc.gov/malaria/resources/pdf/fsp/drugs/hydroxyc...
Can you point to any studies that shows the safety of hydroxycholorquine in people with respiratory distress or infection?
Can you show any studies that hyrdoxychlorquine is safe when the blood oxygen level drops below certain level often seen in covid patients?
Can I point you to here which shows all the potentially dangerous side effects of hydroxychloroquine?
[1] https://www.pdr.net/drug-summary/Plaquenil-hydroxychloroquin...
Interesting aspect is the following:
> Hydroxychloroquine prolongs the QT interval. Use hydroxychloroquine with caution in patients with conditions that may increase the risk of QT prolongation including congenital long QT syndrome, bradycardia, AV block, heart failure, stress-related cardiomyopathy, myocardial infarction, stroke, hypomagnesemia, hypokalemia, hypocalcemia, or in patients receiving medications known to prolong the QT interval or cause electrolyte imbalances. Females, geriatric patients, patients with sleep deprivation, pheochromocytoma, sickle cell disease, hypothyroidism, hyperparathyroidism, hypothermia, systemic inflammation (e.g., human immunodeficiency virus (HIV) infection, fever, and some autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus (SLE), and celiac disease) and patients undergoing apheresis procedures (e.g., plasmapheresis [plasma exchange], cytapheresis) may also be at increased risk for QT prolongation.
Take thalidomide for example. Great drug for treating nausea, but not great when that person is also pregnant. By not studying it in this group, it resulted in many people born with birth defects.
And despite what people are saying, there are some nasty side effects for people with cardiovascular issues.
It's worth noting that infants have died with accidental exposure.
https://www.pdr.net/drug-summary/Plaquenil-hydroxychloroquin...
This is a useful result, but it's not what we've really been wondering. The question of whether HCQ, possibly in combination with antibiotics or zinc and administered early in the infection, reduces the likelihood of getting a serious case.
The Minnesota study has some methodological issues, as well as not enough patients, that made it impossible to draw conclusions about this.
Hopefully, future RCT studies will illuminate this as well. Unless the Lancet paper has poisoned the source of candidates for the study enough that it will be impossible to recruit patients.
They have yet to publish the results on whether it benefits patients during the early onset of symptoms. [1]
Is hydroxychloroquine paired with zinc in the two studies? That has been the central claim of people supporting hydroxychloroquine this entire time and so far I've yet to see them used together in an early treatment / preventative study in the US (perhaps they've done so in Europe or China?).
[1] "A separate U trial is examining whether it benefits patients after early onset of symptoms, but results haven’t been published."
https://www.startribune.com/anti-malaria-drug-in-u-of-m-tria...
https://academic.oup.com/aje/advance-article/doi/10.1093/aje...
One of these "studies" is a 2-page Google Doc with no real data. Another is the discredited Raoult study, which is under investigation by the journal [1]. Another study cited is also by Raoult's team. The Brazil study (ref. 29) doesn't seem to have passed peer review (yet?) and has severe methodological flaws. Like the Raoult studies, the Brazil study was not randomized, but makes no attempt to control for confounding by indication or self-selection, such as with propensity score matching or similar methods commonly used in observational studies. The last study cited isn't a study, but an article from a local news station.
> ...James Watson, a statistician at Mahidol who on 28 May published an open letter to the journal and the study’s co-authors, signed by more than 200 clinicians and researchers, that calls for the release of Surgisphere’s hospital-level data, an independent validation of the results, and publication of the peer review comments that led to the Lancet publication.
This blogger's article is dated May 29.
Given that the underlying theme of this blog is "everyone's lying to you about covid19, it's actually not that big of a deal", I doubt James Todaro was as instrumental in The Lancet's retraction as the letter from 200 other researchers the day before.
It will be quite bad if it turns out that the WHO reacted to a study published in The Lancet that turns out to be fraudulent or grossly erroneous. We don't need to make the situation even worse by lending undue credit to other sources of disinformation.
[1]: https://www.sciencemag.org/news/2020/06/mysterious-company-s...
These successful HCQ studies, full of reports of lives saved, are worthy of attention.
But, I'm completely exhausted.
Between arguing against racists and arguing against bad politics during a global health epidemic and trying to catch and counter some of the relentless stream of disinformation on this and so many other subjects -- and all without any intervention at all from any of the social media platforms that enable all of this, including HN -- I'm tired, and discouraged, and dispirited.
I need to go away for a while. I hope someone else has the time and energy to curb stomp random dude's 25 page Google Doc minutes before someone else cites 25 pages of different BS.
If the list of possible scenarios includes death, and people have invested the time to reach informed conclusions in consultation with their doctors, perhaps their choices can be respected.
https://rheumatology.medicinematters.com/covid-19/hydroxychl...
Will countries now revert national health policy changes that were based on this questionable study? What about the families of patients who were denied early HCQ treatment based on this study? Who is liable for their denial of treatment?
James Todaro, May 29th, https://www.medicineuncensored.com/a-study-out-of-thin-air
> Misinformation is bad. Misinformation in medicine is worse. Misinformation from a prestigious medical journal is the worst. Herein is a detailed look at the controversial Lancet study that resulted in the World Health Organization ending worldwide clinical trials on hydroxychloroquine in order to focus on patented therapeutics.
Guardian, June 3rd, https://www.theguardian.com/world/2020/jun/03/covid-19-surgi...
> The very serious concerns being raised about the validity of the papers by Mehra et al need to be recognised and actioned urgently, and ought to bring about serious reflection on whether the quality of editorial and peer review during the pandemic has been adequate. Scientific publication must above all be rigorous and honest. In an emergency, these values are needed more than ever.
James Todaro helped to bring this questionable study to light—his website (https://www.medicineuncensored.com/) and compilation of HCQ studies (https://docs.google.com/document/d/1O6Cls-Oz2ZAgJuyDbnICEGjM...) may be of interest.